Fiscal Year 2016: See NIH Research Portfolio Online Reporting Tools (RePORT) to examine funding information for projects: https://projectreporter.nih.gov/reporter_summary.cfm and https://report.nih.gov/categorical_spending.aspx.
Fiscal Year 2017: No current data available.
Fiscal Year 2018: No current data available.
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
|Recipient||Amount||Start Date||End Date|
|Trustees Of The University Of Pennsylvania, The||$ 4,197,181||   ||2007-07-01||2024-06-30|
|Trustees Of The University Of Pennsylvania, The||$ 5,319,608||   ||1999-06-01||2024-06-30|
|Trustees Of Indiana University||$ 363,397||   ||2019-07-01||2024-06-30|
|University Of California, San Diego||$ 627,572||   ||2019-08-01||2024-05-31|
|Trustees Of The University Of Pennsylvania, The||$ 2,022,218||   ||2015-05-01||2024-05-31|
|Regents Of The University Of Colorado, The||$ 400,084||   ||2019-08-01||2024-05-31|
|University Of North Carolina At Chapel Hill||$ 496,035||   ||2019-08-06||2024-05-31|
|Charlotte-mecklenburg Hospital Authority, The||$ 616,527||   ||2019-07-23||2024-04-30|
|Trustees Of Columbia University In The City Of New York||$ 112,295||   ||2019-04-17||2024-03-31|
|Washington University, The||$ 640,937||   ||2019-05-15||2024-02-29|
Fiscal Year 2016: 250 Research Grants, 47 NRSA Individual Awards, 131 Institutional FTTPs/22 Institutional Awards. Fiscal Year 2017: 249 Research Grants, 47 NRSA Individual Awards, 131 Institutional FTTPs/22 Institutional Awards. Fiscal Year 2018: 188 Research Grants, 37 NRSA Individual Awards, 102 Institutional FTTPs/21 Institutional Awards.
Uses and Use Restrictions
Research Grants: Funds may be used for salaries, consultation, equipment, travel and other usual costs, subject to Federal regulations applicable to the grant.
National Research Service Awards (NRSAs) (Individual): Individual awards are made to institutions on behalf of the individual for research training in specified areas related to the mission of NINR.
NRSAs (Institutional): Grants may be made to institutions to enable them to accept individuals for research training.
Each individual who receives a NRSA postdoctoral fellowship on an NRSA award must comply with all applicable service and payback provisions.
SBIR Phase I grants: (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process.
STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application.
Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of Phase II application.
Research Grants: Any corporation, public or private institution or agency, or other legal entity, either nonprofit or for-profit, may apply.
NRSAs (Individual): An applicant must be a registered professional nurse with either a baccalaureate and/or a master's degree in nursing and must be a citizen of the United States or lawfully admitted for permanent residence.
Those on temporary or student visas are not eligible.
NRSAs (Institutional): An eligible institution must be capable of providing predoctoral and/or postdoctoral research training opportunities for nurses.
SBIR grants: can be awarded only to domestic small businesses (entities that are independently owned and operated for profit; are not dominant in the field in which research is being proposed; and have no more than 500 employees).
Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project.
In both Phase I and Phase II, the research must be performed in the United States or its possessions.
To be eligible for funding, a grant application must be reviewed for scientific merit and program relevance by a scientific review group and a national advisory council.
STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which 'partner' with a research institution in cooperative research and development.
At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution.
In both Phase I and Phase II, the research must be performed in the U.S.
and its possessions.
To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Individuals and public or private institutions.
Each applicant for research projects must present a research plan and furnish evidence that scientific competence, facilities, equipment, and supplies are appropriate to carry out the plan. NRSAs (Individual): The applicant's academic record, research experience, citizenship, or permanent resident status, licensure as a registered nurse, and institutional sponsorship should be documented in the application. NRSAs (Institutional): The applicant organization must show the objectives, methodology and resources for the research training program, the qualifications and experience of directing staff, the criteria to be used in selecting individuals for awards, and detailed budget justification for the amount of grant funds requested. Costs will be determined in accordance with 2 CFR, Part 220, Cost Principles for Educational Institutions. For-profit organizations' costs are determined in accordance with 48 CFR Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined by HHS Regulations 45 CFR, Part 75. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. The SF 424 (Research and Research-Related) application forms and the SF 424 SBIR/STTR Application Guide are used to apply for both SBIR and STTR, Phase I and Phase II. Application is made electronically through Grants.gov (http://www.grants.gov). 2 CFR 200, Subpart E - Cost Principles applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Research Grants: Applications must be prepared electronically through Grants.gov (http://www.grants.gov) using the SF 424 (Research and Research-Related) application form. The electronic application format is interactive. For assistance submitting an electronic application, contact GrantsInfo: Telephone (301) 435- 0714, Email: GrantsInfo@nih.gov. NRSAs (Individual): Individuals must submit the SF 424 (Research and Research-Related) application form, and include at least three, but no more than five, letters of reference. Letters of reference must be submitted electronically through the NIH eRA Commons Submit Reference Letter website and not through Grants.gov (http://www.grants.gov). Applicants who have lawfully been admitted to the United States for permanent residence must complete the appropriate section on the Face Page of the SF 424 (Research and Research-Related) application form. Applicants who have applied for and have not yet been granted admission as a permanent resident should check the Permanent resident block on the Face Page of this application form, and also write in the word 'pending.' A notarized statement documenting legal admission for permanent residence must be submitted prior to the issuance of an award. SBIR and STTR: The SF 424 (Research and Research-Related) application form and the SF 424 SBIR/STTR Application Guide are used to apply for both SBIR and STTR grants, Phase I and Phase II. Application forms must be submitted electronically through Grants.gov (http://www.grants.gov). For further assistance contact GrantsInfo: Telephone: (301) 435-0714, E-mail: GrantsInfo@nih.gov.
Research Grants and National Research Service Awards (NRSAs) (Institutional): All accepted applications are reviewed for scientific merit by an appropriate initial review group and then by a national advisory council. (Individual NRSA applications are not reviewed by council.) All applications favorably recommended compete for available funds on the basis of scientific merit and mission/program relevance. SBIR/STTR Applications: All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, mission/program relevance, and program balance among the areas of research.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Public Health Service Act, Section 301, 464, 487, 42 U.S.C 285q; Public Health Service Act, Public Law 99-158; Public Health Service Act, Public Law 102-564.
Range of Approval/Disapproval Time
Research Grants: From 6 to 9 months. NRSAs: From 6 to 9 months. SBIR/STTR: About 7-1/2 months. AIDS Grants: About 6 months.
Research Grants: A Program Director/Principal Investigator (PD/PI) and/or applicant institution may question the substantive or procedural aspects of the initial peer review of his/her application by communicating with the appropriate NINR Program Official. NINR follows the NIH Appeals policy, NOT-OD-11-064: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html. NINR works with application PD/PI within the NIH appeals policy.
Research Grants: Renewal applications are accepted. NRSAs: Awards may be made for 1 to 5 years. No individual may receive more than 5 years of aggregate NRSA support beyond the predoctoral level, and no individual may receive NRSA support for more than 3 years of support beyond the postdoctoral level. Institutional awards may be renewed.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
Research Grants: Awards are usually made annually with no project periods to exceed 5 years in length. NRSAs: Institutional awards may be made for up to 5 years; and Individual awards may be made for up to 5 years at the predoctoral level, 3 years at postdoctoral level, and 2 years at senior level. SBIR: Normally, Phase I awards are for 6 months and normally Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year and normally Phase II awards are for 2 years. See the following for information on how assistance is awarded/released: Grant awards are made annually.
Post Assistance Requirements
Research Performance Progress Reports (RPPR) are required for all annual non-competing awards.
Final Progress Reports, Final Federal Financial Reports, and Final Invention Statement and Certification (except for Training grants, Fellowships, and certain other programs [e.g., C06, R13, R25, S10]) for all projects are required within 120 after the end of the research performance period.
Termination Notices are required for Fellowships and trainees appointed on institutional training grants.
No cash reports are required.
Progress reports where applicable are required annually for continuing projects.
Financial status reports where applicable are required annually for continuing projects.
Progress reports where applicable are required annually for continuing projects.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Grantees generally must retain financial and programmatic records, supporting documents, statistical records, and all other records that are required by the terms of a grant, or may reasonably be considered pertinent to a grant, for a period of 3 years from the date the annual Federal Financial Report (FFR) is submitted. For awards under SNAP (other than those to foreign organizations and Federal institutions), the 3-year retention period will be calculated from the date the Final Status Report (FSR) for the entire competitive segment is submitted. Those grantees must retain the records pertinent to the entire competitive segment for 3 years from the date the FSR is submitted to NIH. Foreign organizations and Federal institutions must retain records for 3 years from the date of submission of the annual FSR to NIH. See 45 CFR Part 75.361 for exceptions and qualifications to the 3-year retention requirement (e.g., if any litigation, claim, financial management review, or audit is started before the expiration of the 3-year period, the records must be retained until all litigation, claims, or audit findings involving the records have been resolved and final action taken). Those sections also specify the retention period for other types of grant-related records, including F&A cost proposals and property records. See 45 CFR Part 75.361 and Part 75.364 for record retention and access requirements for contracts under grants. In accordance with 45 CFR 75.364, the HHS Inspector General, the U.S. Comptroller General, or any of their duly authorized representatives have the right of timely and unrestricted access to any books, documents, papers, or other records of recipients that are pertinent to awards in order to make audits, examinations, excerpts, transcripts, and copies of such documents. This right also includes timely and reasonable access to a recipient?s personnel for the purpose of interview and discussion related to such documents. The rights of access are not limited to the required retention period, but shall last as long as records are retained.
(Project Grants) FY 16 $106,770,328; FY 17 est $107,695,000; and FY 18 est $81,102,000 - Research Grants. (Training) FY 16 $7,998,401; FY 17 est $8,346,000; and FY 18 est $6,490,000 - National Research Service Awards (NRSA).
Range and Average of Financial Assistance
FY16 Research Grants: $49,813 to $1,926,591; Average cost $431,880 FY16 NRSA Individual Awards: $1,146 to $58,818; Average cost of FTTP/Award $37,319 FY16 NRSA Institutional Awards: $73,968 to $482,511; Average cost of FTTP $49,069/Average cost of Award $279,478.
Regulations, Guidelines, and Literature
Research Grants: Grants will be available under the authority of and administered in accordance with the NIH Grants Policy Statement and Federal regulations at 42 CFR 52 and 42 USC 241; Omnibus Solicitation of the Public Health Service for Small Business Innovation Research (SBIR) Grant and Cooperative Agreement Applications. Omnibus Solicitation of the National Institutes of Health for Small Business Technology Transfer (STTR) Grant Applications.
Regional or Local Office
Marguerite Littleton Kearney 31 Center Drive, Bethesda, Maryland 20892 Email: firstname.lastname@example.org Phone: (301) 402-7932
Criteria for Selecting Proposals
Reviewers provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed): (1) Significance: Does the project address an important problem or a critical barrier to progress in the field? Is there a strong scientific premise for the proposed project, including consideration of the strengths and weaknesses of published research or preliminary data crucial to the support of the application? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? (2) Investigators: Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project? (3) Innovation: Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed? (4) Approach: Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects? If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of children, justified in terms of the scientific goals and research strategy proposed? (5) Environment: Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements? In addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the impact/priority score. Protections for Human Subjects: For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials. For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. Inclusion of Women, Minorities, and Children: When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of children to determine if it is justified in terms of the scientific goals and research strategy proposed. Vertebrate Animals: The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if not consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section. Biohazards: Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed. Resubmission: The committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project. Renewal: The committee will consider the progress made in the last funding period. Revision: The committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident. Applications compete for available funds with all other recommended applications. The following will be considered in making funding decisions: Scientific merit of the proposed project as determined by peer review; Availability of funds; Relevance of program priorities.